Chemed Corp

Healthcare · Medical Care Facilities

499.80$ +0.3% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Income Statement

Chemed Corp (CHE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 673 million $. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

Tick rows to compare them in a chart (up to 4)

Income Statement CHE
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	393	403	406	415	417	428	439	442	444	458	462	474	481	522	516	502	528	533	527	532	539	541	531	531	526	547	560	554	565	586	589	596	606	640	647	619	625	639	658	673	2,595
Cost of Revenue	282	279	285	286	288	291	305	306	305	313	322	324	328	347	352	352	339	335	340	350	342	336	337	337	347	350	371	374	362	358	385	390	396	406	431	434	444	433	459	469	1,805
Gross Profit	111	124	121	129	129	137	135	136	139	144	140	150	152	175	164	150	189	198	187	182	197	205	194	194	180	197	189	180	202	228	204	206	210	234	216	185	181	206	199	204	790
Research & Development	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Selling, General & Administrative	59	63	69	69	67	72	69	68	67	66	74	72	77	83	71	85	88	87	92	94	89	92	90	88	84	85	100	93	100	100	116	100	102	104	106	99	106	106	114	–	–
Total Operating Expenses	68	71	79	168	75	80	78	78	77	77	91	84	88	98	85	57	115	55	106	110	104	107	105	103	99	116	117	110	115	116	132	118	118	120	122	117	106	106	114	115	441
Operating Income	43	53	41	-39	54	57	56	58	62	67	49	66	65	77	79	93	74	143	80	72	93	98	89	92	81	81	73	70	87	111	72	88	92	114	95	68	75	101	85	89	349
Interest Expense	1.0	0.9	1.0	1.1	1.0	1.1	1.2	1.5	1.1	1.2	1.1	1.2	1.0	1.1	1.0	0.7	0.4	0.4	0.4	0.4	0.6	0.5	0.8	0.9	1.3	1.6	1.6	0.8	0.4	0.3	0.4	0.4	0.4	0.5	0.3	0.4	2.0	0.5	0.5	1.8	4.8
Pre-Tax Income	43	52	43	-38	54	58	56	58	63	63	51	64	67	80	69	100	82	146	84	75	95	96	85	86	76	82	71	70	93	116	84	94	101	120	96	71	84	105	89	91	369
Income Tax Expense	17	20	13	-17	19	3.6	11	2.7	12	8.5	6.1	14	8.0	14	13	18	14	32	18	19	23	22	21	20	20	20	17	17	18	26	19	23	25	30	24	19	19	29	23	24	94
Net Income	27	32	30	-22	35	55	45	55	51	54	45	51	59	66	56	82	68	114	65	57	72	75	64	66	57	62	54	53	75	90	65	71	76	90	72	52	64	77	66	68	275
EBITDA	53	62	53	-28	64	68	67	69	74	74	62	76	79	95	84	114	96	161	98	92	110	111	100	102	92	99	88	86	109	131	101	110	117	136	112	88	102	122	106	101	432

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings